Extended Phase 1b trial follow-up on IMA203 PRAME cell therapy in 33 heavily pretreated patients with metastatic melanoma demonstrates favorable…
FRANKFURT, Germany, May 29, 2025 /PRNewswire/ -- Qualifyze, already the global leader in third-party audit services for the pharmaceutical industry,…
Two pioneering scientists received The Brain Prize 2025 for their discoveries that open an entirely new way of thinking about…
FRANKFURT, Germany, May 29, 2025 /PRNewswire/ -- The financial world is undergoing a revolutionary transformation, and NYALA Digital Asset AG is…